BioCentury | Sep 13, 2018
Emerging Company Profile

Mapping tumor markers

...raised $1.8 million in seed funding; Tumeh declined to disclose other funding plans. COMPANY PROFILE BioGraph 55 Inc....
...Undisclosed CEO: Paul Tumeh Patents: Undisclosed Companies and Institutions Mentioned AbbVie Inc. (NYSE:ABBV), Chicago, Ill. BioGraph 55 Inc....
...Writer Programmed cell death 1 (PD-1) (PDCD1) (CD279) Programmed cell death 1 ligand 1 (PD-L1) (B7-H1) (CD274) Cancer (unspecified) BioGraph 55 Inc....
Items per page:
1 - 1 of 1
BioCentury | Sep 13, 2018
Emerging Company Profile

Mapping tumor markers

...raised $1.8 million in seed funding; Tumeh declined to disclose other funding plans. COMPANY PROFILE BioGraph 55 Inc....
...Undisclosed CEO: Paul Tumeh Patents: Undisclosed Companies and Institutions Mentioned AbbVie Inc. (NYSE:ABBV), Chicago, Ill. BioGraph 55 Inc....
...Writer Programmed cell death 1 (PD-1) (PDCD1) (CD279) Programmed cell death 1 ligand 1 (PD-L1) (B7-H1) (CD274) Cancer (unspecified) BioGraph 55 Inc....
Items per page:
1 - 1 of 1